Back to Search
Start Over
Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion.
- Source :
-
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2013 Jul; Vol. 10 (3), pp. 520-38. - Publication Year :
- 2013
-
Abstract
- Spinal cord injury (SCI) causes not only sensorimotor and cognitive deficits, but frequently also severe chronic pain that is difficult to treat (SCI pain). We previously showed that hyperesthesia, as well as spontaneous pain induced by electrolytic lesions in the rat spinothalamic tract, is associated with increased spontaneous and sensory-evoked activity in the posterior thalamic nucleus (PO). We have also demonstrated that rodent impact SCI increases cell cycle activation (CCA) in the injury region and that post-traumatic treatment with cyclin dependent kinase inhibitors reduces lesion volume and motor dysfunction. Here we examined whether CCA contributes to neuronal hyperexcitability of PO and hyperpathia after rat contusion SCI, as well as to microglial and astroglial activation (gliopathy) that has been implicated in delayed SCI pain. Trauma caused enhanced pain sensitivity, which developed weeks after injury and was correlated with increased PO neuronal activity. Increased CCA was found at the thoracic spinal lesion site, the lumbar dorsal horn, and the PO. Increased microglial activation and cysteine-cysteine chemokine ligand 21 expression was also observed in the PO after SCI. In vitro, neurons co-cultured with activated microglia showed up-regulation of cyclin D1 and cysteine-cysteine chemokine ligand 21 expression. In vivo, post-injury treatment with a selective cyclin dependent kinase inhibitor (CR8) significantly reduced cell cycle protein induction, microglial activation, and neuronal activity in the PO nucleus, as well as limiting chronic SCI-induced hyperpathia. These results suggest a mechanistic role for CCA in the development of SCI pain, through effects mediated in part by the PO nucleus. Moreover, cell cycle modulation may provide an effective therapeutic strategy to improve reduce both hyperpathia and motor dysfunction after SCI.
- Subjects :
- Action Potentials drug effects
Animals
Cell Cycle drug effects
Cell Proliferation drug effects
Cells, Cultured
Cyclins pharmacology
Cyclins therapeutic use
Disease Models, Animal
Enzyme Inhibitors pharmacology
Exploratory Behavior drug effects
Follow-Up Studies
Gene Expression Regulation drug effects
Glial Fibrillary Acidic Protein metabolism
Gliosis drug therapy
Gliosis etiology
Male
Microglia chemistry
Microglia metabolism
Microglia pathology
Nerve Fibers, Unmyelinated pathology
Neurons drug effects
Pain Threshold drug effects
Pain Threshold physiology
Posterior Thalamic Nuclei drug effects
Posterior Thalamic Nuclei pathology
Rats
Rats, Sprague-Dawley
Spinal Cord Injuries drug therapy
Spinal Cord Injuries pathology
Time Factors
Cell Cycle physiology
Gene Expression Regulation physiology
Hyperesthesia etiology
Hyperesthesia pathology
Posterior Thalamic Nuclei physiopathology
Spinal Cord Injuries complications
Subjects
Details
- Language :
- English
- ISSN :
- 1878-7479
- Volume :
- 10
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 23775067
- Full Text :
- https://doi.org/10.1007/s13311-013-0198-1